Dren Bio
Foster City, US · Founded 2019 · Delaware corporation · 8 known investors
Dren Bio is a clinical-stage biopharmaceutical company developing novel antibody therapeutics designed to selectively eliminate pathogenic cells and disease-causing agents, with a pipeline targeting oncology, autoimmune diseases, immunology, and neurology.
Founders & leadership
Dren Bio was founded in 2019 by Nenad Tomasevic.
NT
Nenad TomasevicFounder
Board
IT
Ivan TrifunovichBoard director
JW
John WesleyBoard director
Investors · 8
8VCAustin · $100K – $50Mvia Alex Kolicich · board
Aisling CapitalNew York
Mission Bay CapitalSan Francisco
Mission BiocapitalSan Francisco · $500K
Olive Tree CapitalBoston
SR One Capital ManagementRedwood Cityvia Rajeev Dadoo · board
Taiho Ventures, LLCMenlo Parkvia Sakae Asanuma · board
HBM Healthcare InvestmentsreportedZug
Reported raises · per SEC filings
Form D private placements$93.1M disclosed across 3 rounds · 2019–2022
▶$62.5MraisedMar 2022 · 27 investors · BiotechnologyRule 506(b)
▶$62.5MraisedMar 2022 · 27 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Rajeev DadooDirector
- Nenad TomasevicExecutive Officer, Director
- Andrew N. SchiffDirector
- Alex KolicichDirector
- Chandra LeoDirector
- Kenneth R LuehrsenDirector
- Sakae AsanumaDirector
- Offering amount
- $80M
- Amount sold
- $62.5M
- First sale
- Mar 2022
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$25.5MraisedNov 2020 · 11 investors · BiotechnologyRule 506(b)
▶$25.5MraisedNov 2020 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Alex KolicichDirector
- Rajeev DadooDirector
- Sakae AsanumaDirector
- John WesleyDirector
- Nenad TomasevicExecutive Officer, Director
- Offering amount
- $60M
- Amount sold
- $25.5M
- First sale
- Aug 2020
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$5.1MraisedJul 2019 · 19 investors · OtherRule 506(b)
▶$5.1MraisedJul 2019 · 19 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Nenad TomasevicExecutive Officer, Director
- Ivan TrifunovichDirector
- John WesleyDirector
- Offering amount
- $6M
- Amount sold
- $5.1M
- First sale
- Jul 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlapRenBio22 shared keywordsRenBio develops DNA-based therapeutic technology that uses intramuscular injection of therapeutic-encoding "bioblueprints" so a patient's own muscle cells produce antibodies and therapeutic proteins to prevent and treat diseases, including infectious diseases. The company works in the antibody and therapeutic protein field, aiming to overcome obstacles in delivery, durability, and cost.
Mission BioCapital Platinum Program Holdings LLC16 shared keywordsMission BioCapital is an early-stage venture capital firm that provides capital and shared lab space to life science startups, supporting founders from initial experiments through to the clinic. Founded in 2009, it invests in early-stage life science companies and is currently deploying its fifth fund.
Companies competing with Dren Bio for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Dren Bio do?
- Dren Bio is a clinical-stage biopharmaceutical company developing novel antibody therapeutics designed to selectively eliminate pathogenic cells and disease-causing agents, with a pipeline targeting oncology, autoimmune diseases, immunology, and neurology.
- Who founded Dren Bio?
- Dren Bio was founded by Nenad Tomasevic in 2019.
- Who are Dren Bio's investors?
- Dren Bio's investors include 8VC, Aisling Capital, Mission Bay Capital, Mission Biocapital, Olive Tree Capital, SR One Capital Management, Taiho Ventures, LLC, HBM Healthcare Investments.
- How much funding has Dren Bio raised?
- Dren Bio has disclosed $93.1M raised across 3 rounds.
- Where is Dren Bio headquartered?
- Dren Bio is headquartered in Foster City, US.